Melanotan I: A Research Overview
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
- Melanotan I is a lab-made copy of a natural body signal called alpha-MSH, and it is studied for how it acts on melanocortin receptors, which are switches involved in skin pigment.
- Most of the solid human research is on a closely related drug called afamelanotide, not on Melanotan I itself; Melanotan I has a much thinner evidence base, and a lot of what exists comes from cell and animal studies that do not directly carry over to people.
- Reports about effects in people that circulate in online communities are unverified personal stories, not controlled studies, and BioRegen does not make or endorse any of those claims.
- Melanotan I is not approved for human or veterinary use; the related afamelanotide has approval only for one narrow skin condition.
- BioRegen supplies Melanotan I strictly for laboratory and educational research, not for use in humans or animals, and nothing here is medical advice.
Melanotan I is a lab-made copy of a natural body chemical called alpha-MSH (the full name is alpha-melanocyte-stimulating hormone). Scientists have studied it a lot when they look at a body signaling system called the melanocortin pathway. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page sums up how researchers describe the compound, what published studies have looked at, and the limits that shape what we actually know so far.
What Melanotan I Is
Melanotan I is a small chain made of 13 amino acids, the building blocks of proteins. It is a close relative of a compound called afamelanotide, which has been tested in clinical studies. Melanotan I is based on the shape of alpha-MSH, a chemical the body makes on its own. Alpha-MSH works by attaching to docking points on cells called melanocortin receptors. In research papers, Melanotan I is described as a compound that switches these receptors on, and it lasts longer in the body than the natural version, which is one reason labs study it so often. When this article talks about the compound, it is only repeating how published, peer-reviewed studies describe it. It is not suggesting any use.
Mechanism and What Research Explores
The melanocortin system uses five kinds of receptors, named MC1R through MC5R. Scientists have studied their roles in skin and hair color, energy use, and inflammation. In published research, Melanotan I and its relative afamelanotide are described as acting mainly on the first one, MC1R, which sits on pigment-making cells called melanocytes. Studies have looked at how turning on MC1R is linked to making eumelanin, a dark pigment. That link is the main question researchers connect to this group of compounds. To study it, investigators watch how the compound attaches to the receptor, what signals fire inside the cell afterward, and how pigment is made, all in cell and tissue samples. This helps them learn how small changes in a compound's structure change what it does.
Research Stage and Limitations
The strongest research in this family is on afamelanotide. It has been tested in large, carefully run clinical trials across many sites, in people with a rare skin condition that reacts badly to light. Melanotan I itself, the kind sold for lab study, has far less evidence behind it. It is best thought of as a research material still being studied, not a proven treatment. Researchers point out some important limits. The lab-grade peptide is not the same as a drug made for patients. Different studies use different methods, so results can be hard to compare. And much of the data comes from cells or animals, which does not always carry over to people. There is also chatter about this compound online, but those are personal stories, not controlled studies. BioRegen does not make or back up any claims based on them.
Handling and Laboratory Notes
Research peptides like this usually come as a dry powder (a process called freeze-drying, or lyophilizing). Lab guides generally say to keep that powder cold and away from light and moisture. In the lab, researchers mix it back into a liquid using a suitable fluid under careful conditions. For general background on getting freeze-dried material ready in a lab, see our overview on how to reconstitute peptides. These notes describe normal lab practice for teaching purposes. They are not directions for any use in people or animals.
Frequently Asked Questions
How does Melanotan I differ from Melanotan II?
In research papers they are two different peptides. Melanotan I is a straight-chain copy of alpha-MSH, closely related to afamelanotide, and it tends to act mostly on the MC1R receptor. Melanotan II is a ring-shaped peptide that is reported to act on a wider mix of melanocortin receptors. Researchers treat them as separate compounds that work on different receptors.
Is Melanotan I approved for any use?
No compound mentioned here is approved for use in people or animals. The close relative afamelanotide has been tested in regulated clinical trials, but lab-grade Melanotan I sold for research is meant only for lab tests and learning.
Where can I compare related research compounds?
Our research finder lets labs browse and compare melanocortin and other research peptides by their documented research traits.
Selected Research References
- Langendonk JG, et al. Afamelanotide for Erythropoietic Protoporphyria. N Engl J Med. https://doi.org/10.1056/NEJMoa1411481
- Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. J Drugs Dermatol. https://doi.org/10.36849/JDD.5526
Reference metadata sourced via PubMed.
Continue Your Research
For more background on planning a study and picking research materials, explore the BioRegen research guide, and create a free account for 10% off your first order. You can also browse related melanocortin and research peptides in our research catalog category.
This article is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, and nothing here constitutes medical advice. BioRegen does not endorse any claim regarding the use of these compounds in humans or animals.